designer491/iStock via Getty Images
Valneva (VALN) and the world’s largest vaccine maker, Serum Institute of India, announced on Wednesday that they have mutually agreed to discontinue their licensing agreement for the former’s chikungunya vaccine.
The companies identified the decision as a strategic move aimed
Follow us on Google for the latest stock news
Lewis Von Thaer, a Director at KBR (NYSE:KBR), reported an open-market purchase of 3,000 common shares on May 14, 2026,...
Israeli managed AI delivery platform Unframe, today announced the completion of a $50 million financing round led by Highland...
Eltek press release (ELTK): Q1 GAAP EPS of -$0.42. Revenue of $10.4M (-18.8% Y/Y). Net cash used in operating activities...
One of the world’s most contentious AI companies just took its first outside investment. The check came from the Chinese...
Sameer Dalal from Natverlal & Sons Stockbrokers said Indian markets continue to receive support from strong domestic liquidity, particularly sustained...
The two big redistricting news stories, of late, represent a one-two punch that set back Democrats’ midterm election prospects. First,...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
